What Polivy is
Polivy is a cancer medicine that contains the active substance polatuzumab vedotin. It is always used together with other cancer medicines – see below “What other medicines is Polivy given with”.
What is Polivy used for
Polivy is given to treat “diffuse large B - cell lymphoma” that has never been treated before. Polivy is also given to treat “diffuse large B - cell lymphoma” that has come back or has not got better:
- after at least one previous therapy, and
- when you cannot receive a stem cell transplant.
“Diffuse large B - cell lymphoma” is a cancer that comes from “B lymphocytes” also called B - cells. These are a type of blood cells.
How Polivy works
Polivy contains something called a ‘monoclonal antibody’ and a substance that can kill cancer called ‘MMAE’.
- The “monoclonal antibody” part of the medicine attaches to a target on B cells.
- Once attached to B cells, the medicine releases “MMAE” into the B cells and kills them.
What other medicines Polivy is given with
Polivy is given in combination with other cancer medicines:
- rituximab, cyclophosphamide, doxorubicin and prednisone for “diffuse large B - cell lymphoma” that has never been treated before.
- rituximab and bendamustine for “diffuse large B - cell lymphoma” that has come back or has not got better, after at least one previous therapy – and when you cannot receive a stem cell transplant.